United States Healthcare Equipment & Supplies

Novocure Ltd (NVCR)

Track

Over the past 90 days, Novocure Ltd insiders have exclusively engaged in selling activity, totaling approximately $2.17 million in divestments. Notable transactions include significant sales by CEO Frank Leonard and other executives. These sales occurred following the company's recent earnings report, amid a 29.6% increase in stock price over the same period.
Ticker: NVCR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novocure Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Leonard Frank X
Chief Executive Officer
2 sales — total 1,229,270 USD
Sale 4 Jun 2026
Value US$4,602,223.45 | Price 10.33 | Shares 57,399
Sale 4 Jun 2026
Value US$2,035,793.33 | Price 212.00 | Shares 95,650
Proposed sale 4 Jun 2026
Value US$3,578,426.58 | Price 478.36 | Shares 1,868
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 2 Jun 2026
Value US$46,444.71 | Price 15.77 | Shares 2,945
Sale 5 Mar 2026
Value US$595,670.40 | Price 13.77 | Shares 43,246
Proposed sale 5 Mar 2026
Value US$595,681.68 | Price 13.77 | Shares 43,246
Sale 4 Mar 2026
Value US$14,635.94 | Price 13.31 | Shares 1,100
Sale 4 Mar 2026
Value US$74,603.38 | Price 13.31 | Shares 5,607
Sale 4 Mar 2026
Value US$71,543.14 | Price 13.31 | Shares 5,377
Sale 4 Mar 2026
Value US$85,314.22 | Price 13.31 | Shares 6,412
Sale 4 Mar 2026
Value US$85,314.22 | Price 13.31 | Shares 6,412
Sale 4 Mar 2026
Value US$14,635.94 | Price 13.31 | Shares 1,100
Proposed sale 4 Mar 2026
Value US$85,314.22 | Price 13.31 | Shares 6,412
Proposed sale 4 Mar 2026
Value US$85,314.22 | Price 13.31 | Shares 6,412
Proposed sale 4 Mar 2026
Value US$71,543.14 | Price 13.31 | Shares 5,377
Proposed sale 4 Mar 2026
Value US$74,603.38 | Price 13.31 | Shares 5,607
Sale 3 Mar 2026
Value US$286,436.30 | Price 13.43 | Shares 21,330
Sale 3 Mar 2026
Value US$646,447.08 | Price 12.79 | Shares 50,557
Proposed sale 3 Mar 2026
Value US$932,884.79 | Price 12.98 | Shares 71,887
Sale 2 Mar 2026
Value US$5,505.14 | Price 13.49 | Shares 408
Sale 2 Mar 2026
Value US$97,581.38 | Price 13.49 | Shares 7,232
Sale 2 Mar 2026
Value US$43,606.93 | Price 13.33 | Shares 3,272
Proposed sale 2 Mar 2026
Value US$97,581.38 | Price 13.49 | Shares 7,232
Proposed sale 2 Mar 2026
Value US$43,606.93 | Price 13.33 | Shares 3,272
Sale 27 Feb 2026
Value US$21,247.21 | Price 13.66 | Shares 1,555
Sale 27 Feb 2026
Value US$14,060.05 | Price 13.66 | Shares 1,029
Sale 27 Feb 2026
Value US$19,689.54 | Price 13.66 | Shares 1,441
Sale 27 Feb 2026
Value US$133,003.43 | Price 13.66 | Shares 9,734
Sale 27 Feb 2026
Value US$103,256.51 | Price 13.84 | Shares 7,461
Proposed sale 27 Feb 2026
Value US$133,003.43 | Price 13.66 | Shares 9,734
Proposed sale 27 Feb 2026
Value US$103,256.51 | Price 13.84 | Shares 7,461
Buy 5 Sep 2025
Value US$996,859.04 | Price 12.22 | Shares 81,550
Buy 29 Jul 2025
Value US$57,500.00 | Price 11.50 | Shares 5,000
Buy 29 Jul 2025
Value US$58,000.00 | Price 11.60 | Shares 5,000
Buy 29 Jul 2025
Value US$116,300.00 | Price 11.63 | Shares 10,000
Sale 3 Jun 2025
Value US$17,299.18 | Price 17.32 | Shares 999
Sale 3 Jun 2025
Value US$17,258.92 | Price 17.28 | Shares 999
Sale 3 Jun 2025
Value US$17,297.29 | Price 17.31 | Shares 999
Sale 3 Jun 2025
Value US$17,175.61 | Price 17.19 | Shares 999
Sale 3 Jun 2025
Value US$17,279.50 | Price 17.30 | Shares 999
Sale 3 Jun 2025
Value US$17,329.25 | Price 17.35 | Shares 999
Sale 3 Jun 2025
Value US$17,269.01 | Price 17.29 | Shares 999
Sale 3 Jun 2025
Value US$17,246.54 | Price 17.26 | Shares 999
Planned sale 2 Jun 2025
Value US$35,721.86 | Price 19.01 | Shares 1,879
Planned sale 2 Jun 2025
Value US$118,732.68 | Price 17.99 | Shares 6,600
Planned sale 2 Jun 2025
Value US$373,958.05 | Price 17.22 | Shares 21,717
Proposed sale 2 Jun 2025
Value US$577,045.56 | Price 19.11 | Shares 30,196
Proposed sale 5 May 2025
Value US$10,604.14 | Price 17.91 | Shares 592
Sale 3 May 2025
Value US$10,604.20 | Price 17.91 | Shares 592
Sale 3 Mar 2025
Value US$46,841.23 | Price 18.54 | Shares 2,527
Sale 3 Mar 2025
Value US$4,634.08 | Price 18.54 | Shares 250
Sale 3 Mar 2025
Value US$5,071.02 | Price 18.92 | Shares 268
Sale 3 Mar 2025
Value US$38,055.02 | Price 18.54 | Shares 2,053
Proposed sale 3 Mar 2025
Value US$46,841.23 | Price 18.54 | Shares 2,527
Proposed sale 3 Mar 2025
Value US$4,634.08 | Price 18.54 | Shares 250
Proposed sale 3 Mar 2025
Value US$5,070.99 | Price 18.92 | Shares 268
Proposed sale 3 Mar 2025
Value US$38,055.02 | Price 18.54 | Shares 2,053
Proposed sale 3 Mar 2025
Value US$58,667.39 | Price 18.54 | Shares 3,165
Sale 28 Feb 2025
Value US$50,647.51 | Price 18.28 | Shares 2,770
Sale 28 Feb 2025
Value US$6,728.62 | Price 18.28 | Shares 368
Sale 28 Feb 2025
Value US$5,695.28 | Price 18.31 | Shares 311
Sale 28 Feb 2025
Value US$81,253.96 | Price 18.78 | Shares 4,326
Sale 28 Feb 2025
Value US$42,803.55 | Price 18.28 | Shares 2,341
Proposed sale 28 Feb 2025
Value US$86,948.81 | Price 18.75 | Shares 4,637
Proposed sale 28 Feb 2025
Value US$6,728.59 | Price 18.28 | Shares 368
Proposed sale 28 Feb 2025
Value US$42,803.31 | Price 18.28 | Shares 2,341
Proposed sale 28 Feb 2025
Value US$58,546.01 | Price 18.28 | Shares 3,202
Proposed sale 28 Feb 2025
Value US$50,647.23 | Price 18.28 | Shares 2,770
Sale 27 Feb 2025
Value US$3,308.39 | Price 20.55 | Shares 161
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
57,399 -9.0%
10.33
US$4,602,223 		57,399 -9.0% 10.33 US$4,602,223
2026-06-05 2026-06-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
95,650 -25.4%
212.00
US$2,035,793 		95,650 -25.4% 212.00 US$2,035,793
2026-06-04 2026-06-04 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
1,868
478.36
US$3,578,427 		1,868 478.36 US$3,578,427
2026-06-03 2026-06-02 S Sale
2.9
HILLEMAN JERYL L
Non-Executive Director
2,945 -17.5%
15.77
US$46,445 		2,945 -17.5% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.5
LEUNG GABRIEL
Non-Executive Director
2,945 -3.2%
15.77
US$46,445 		2,945 -3.2% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
3.2
VERNON W ANTHONY
Non-Executive Director
2,945 -1.5%
15.77
US$46,445 		2,945 -1.5% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.5
Ocean Allyson J
Non-Executive Director
2,945 -20.6%
15.77
US$46,445 		2,945 -20.6% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.6
Scannell Timothy J
Non-Executive Director
2,945 -17.1%
15.77
US$46,445 		2,945 -17.1% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
2.5
Stafford Kristin
Non-Executive Director
2,945 -20.6%
15.77
US$46,445 		2,945 -20.6% 15.77 US$46,445
2026-06-03 2026-06-02 S Sale
3.6
Hung David
Non-Executive Director
2,945 -12.6%
15.77
US$46,445 		2,945 -12.6% 15.77 US$46,445
2026-03-05 2026-03-05 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
43,246 -37.3%
13.77
US$595,670 		43,246 -37.3% 13.77 US$595,670
2026-03-05 2026-03-05 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
43,246
13.77
US$595,682 		43,246 13.77 US$595,682
2026-03-05 2026-03-04 S Sale
2.6
Leupin Nicolas

Former Chief Medical Officer

Officer
1,100 -1.1%
13.31
US$14,636 		1,100 -1.1% 13.31 US$14,636
2026-03-05 2026-03-04 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
5,607 -1.1%
13.31
US$74,603 		5,607 -1.1% 13.31 US$74,603
2026-03-05 2026-03-04 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
5,377 -4.4%
13.31
US$71,543 		5,377 -4.4% 13.31 US$71,543
2026-03-05 2026-03-04 S Sale
2.6
Brackmann Christoph

Chief Financial Officer

Officer
6,412 -3.4%
13.31
US$85,314 		6,412 -3.4% 13.31 US$85,314
2026-03-05 2026-03-04 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
6,412 -2.3%
13.31
US$85,314 		6,412 -2.3% 13.31 US$85,314
2026-03-05 2026-03-04 S Sale
2.4
Puri Michal Nath

Chief Human Resources Officer

Officer
1,100 -0.5%
13.31
US$14,636 		1,100 -0.5% 13.31 US$14,636
2026-03-04 2026-03-04 PrS Proposed sale
2.6
CHRISTOPH BRACKMANN

Officer

Officer
6,412
13.31
US$85,314 		6,412 13.31 US$85,314
2026-03-04 2026-03-04 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
6,412
13.31
US$85,314 		6,412 13.31 US$85,314
2026-03-04 2026-03-04 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
5,377
13.31
US$71,543 		5,377 13.31 US$71,543
2026-03-04 2026-03-04 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
5,607
13.31
US$74,603 		5,607 13.31 US$74,603
2026-03-05 2026-03-03 S Sale
2.2
DOYLE WILLIAM F

Executive Chairman

Executive Director
21,330 -6.1%
13.43
US$286,436 		21,330 -6.1% 13.43 US$286,436
2026-03-05 2026-03-03 S Sale
2.2
DOYLE WILLIAM F

Executive Chairman

Executive Director
50,557 -12.6%
12.79
US$646,447 		50,557 -12.6% 12.79 US$646,447
2026-03-03 2026-03-03 PrS Proposed sale
2.2
WILLIAM DOYLE

Officer; Director

Executive Director
71,887
12.98
US$932,885 		71,887 12.98 US$932,885
2026-03-03 2026-03-02 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
408 -0.5%
13.49
US$5,505 		408 -0.5% 13.49 US$5,505
2026-03-03 2026-03-02 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
7,232 -2.0%
13.49
US$97,581 		7,232 -2.0% 13.49 US$97,581
2026-03-03 2026-03-02 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
3,272 -1.4%
13.33
US$43,607 		3,272 -1.4% 13.33 US$43,607
2026-03-02 2026-03-02 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
7,232
13.49
US$97,581 		7,232 13.49 US$97,581
2026-03-02 2026-03-02 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
3,272
13.33
US$43,607 		3,272 13.33 US$43,607
2026-03-03 2026-02-27 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
1,555 -2.0%
13.66
US$21,247 		1,555 -2.0% 13.66 US$21,247
2026-03-03 2026-02-27 S Sale
2.6
Leupin Nicolas

Former Chief Medical Officer

Officer
1,029 -1.0%
13.66
US$14,060 		1,029 -1.0% 13.66 US$14,060
2026-03-03 2026-02-27 S Sale
2.4
Puri Michal Nath

Chief Human Resources Officer

Officer
1,441 -0.9%
13.66
US$19,690 		1,441 -0.9% 13.66 US$19,690
2026-03-03 2026-02-27 S Sale
4.0
Leonard Frank X

Chief Executive Officer

Officer
9,734 -2.8%
13.66
US$133,003 		9,734 -2.8% 13.66 US$133,003
2026-03-03 2026-02-27 S Sale
2.4
Weinberg Uri

Chf Medical and Innovation Ofr

Officer
7,461 -3.4%
13.84
US$103,257 		7,461 -3.4% 13.84 US$103,257
2026-02-27 2026-02-27 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
9,734
13.66
US$133,003 		9,734 13.66 US$133,003
2026-02-27 2026-02-27 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
7,461
13.84
US$103,257 		7,461 13.84 US$103,257
2025-09-08 2025-09-05 B Purchase
4.2
Cordova Ashley

Chief Executive Officer

Officer
81,550 +22.9%
12.22
US$996,859 		81,550 +22.9% 12.22 US$996,859
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
5,000 +3.7%
11.50
US$57,500 		5,000 +3.7% 11.50 US$57,500
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
5,000 +3.8%
11.60
US$58,000 		5,000 +3.8% 11.60 US$58,000
2025-07-30 2025-07-29 B Purchase
2.6
Brackmann Christoph

Chief Financial Officer

Officer
10,000 +8.3%
11.63
US$116,300 		10,000 +8.3% 11.63 US$116,300
2025-06-04 2025-06-03 S Sale
2.6
Scannell Timothy J
Non-Executive Director
999 -14.2%
17.32
US$17,299 		999 -14.2% 17.32 US$17,299
2025-06-04 2025-06-03 S Sale
2.5
Stafford Kristin
Non-Executive Director
999 -24.6%
17.28
US$17,259 		999 -24.6% 17.28 US$17,259
2025-06-04 2025-06-03 S Sale
2.5
LEUNG GABRIEL
Non-Executive Director
999 -1.2%
17.31
US$17,297 		999 -1.2% 17.31 US$17,297
2025-06-04 2025-06-03 S Sale
2.4
Madden Martin J.
Non-Executive Director
999 -5.1%
17.19
US$17,176 		999 -5.1% 17.19 US$17,176
2025-06-04 2025-06-03 S Sale
3.6
Hung David
Non-Executive Director
999 -7.6%
17.30
US$17,280 		999 -7.6% 17.30 US$17,280
2025-06-04 2025-06-03 S Sale
3.2
VERNON W ANTHONY
Non-Executive Director
999 -0.6%
17.35
US$17,329 		999 -0.6% 17.35 US$17,329
2025-06-04 2025-06-03 S Sale
2.5
Ocean Allyson J
Non-Executive Director
999 -24.6%
17.29
US$17,269 		999 -24.6% 17.29 US$17,269
2025-06-04 2025-06-03 S Sale
2.9
HILLEMAN JERYL L
Non-Executive Director
999 -15.2%
17.26
US$17,247 		999 -15.2% 17.26 US$17,247
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
1,879 -1.1%
19.01
US$35,722 		1,879 -1.1% 19.01 US$35,722
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
6,600 -3.7%
17.99
US$118,733 		6,600 -3.7% 17.99 US$118,733
2025-06-04 2025-06-02 PlS Planned sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
21,717 -10.9%
17.22
US$373,958 		21,717 -10.9% 17.22 US$373,958
2025-06-02 2025-06-02 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
30,196
19.11
US$577,046 		30,196 19.11 US$577,046
2025-05-05 2025-05-05 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
592
17.91
US$10,604 		592 17.91 US$10,604
2025-05-05 2025-05-03 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
592 -0.7%
17.91
US$10,604 		592 -0.7% 17.91 US$10,604
2025-03-04 2025-03-03 S Sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
2,527 -1.7%
18.54
US$46,841 		2,527 -1.7% 18.54 US$46,841
2025-03-04 2025-03-03 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
250 -0.8%
18.54
US$4,634 		250 -0.8% 18.54 US$4,634
2025-03-04 2025-03-03 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
268 -0.2%
18.92
US$5,071 		268 -0.2% 18.92 US$5,071
2025-03-04 2025-03-03 S Sale
4.2
Cordova Ashley

Chief Executive Officer

Officer
2,053 -1.0%
18.54
US$38,055 		2,053 -1.0% 18.54 US$38,055
2025-03-03 2025-03-03 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
2,527
18.54
US$46,841 		2,527 18.54 US$46,841
2025-03-03 2025-03-03 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
250
18.54
US$4,634 		250 18.54 US$4,634
2025-03-03 2025-03-03 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
268
18.92
US$5,071 		268 18.92 US$5,071
2025-03-03 2025-03-03 PrS Proposed sale
4.2
ASHLEY CORDOVA

Officer

Officer
2,053
18.54
US$38,055 		2,053 18.54 US$38,055
2025-03-03 2025-03-03 PrS Proposed sale
3.7
WILHELMUS GROENHUYSEN

Officer

Officer
3,165
18.54
US$58,667 		3,165 18.54 US$58,667
2025-03-03 2025-02-28 S Sale
4.0
Leonard Frank X

EVP, Pres., Novocure Oncology

Officer
2,770 -1.9%
18.28
US$50,648 		2,770 -1.9% 18.28 US$50,648
2025-03-03 2025-02-28 S Sale
2.8
Paravasthu Mukund

Chief Operating Officer

Officer
368 -1.2%
18.28
US$6,729 		368 -1.2% 18.28 US$6,729
2025-03-03 2025-02-28 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
311 -0.2%
18.31
US$5,695 		311 -0.2% 18.31 US$5,695
2025-03-03 2025-02-28 S Sale
2.4
Weinberg Uri

Chief Innovation Officer

Officer
4,326 -2.5%
18.78
US$81,254 		4,326 -2.5% 18.78 US$81,254
2025-03-03 2025-02-28 S Sale
4.2
Cordova Ashley

Chief Executive Officer

Officer
2,341 -1.1%
18.28
US$42,804 		2,341 -1.1% 18.28 US$42,804
2025-02-28 2025-02-28 PrS Proposed sale
2.4
URI WEINBERG

Officer

Officer
4,637
18.75
US$86,949 		4,637 18.75 US$86,949
2025-02-28 2025-02-28 PrS Proposed sale
2.8
MUKUND PARAVASTHU

Officer

Officer
368
18.28
US$6,729 		368 18.28 US$6,729
2025-02-28 2025-02-28 PrS Proposed sale
4.2
ASHLEY CORDOVA

Officer

Officer
2,341
18.28
US$42,803 		2,341 18.28 US$42,803
2025-02-28 2025-02-28 PrS Proposed sale
3.7
WILHELMUS GROENHUYSEN

Officer

Officer
3,202
18.28
US$58,546 		3,202 18.28 US$58,546
2025-02-28 2025-02-28 PrS Proposed sale
4.0
FRANCIS LEONARD

Officer

Officer
2,770
18.28
US$50,647 		2,770 18.28 US$50,647
2025-03-03 2025-02-27 S Sale
2.6
Leupin Nicolas

Chief Medical Officer

Officer
161 -0.3%
20.55
US$3,308 		161 -0.3% 20.55 US$3,308
Explore more

More insider trading research around Novocure Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America